NCT04782869

Brief Summary

This project aims to conduct a pilot study based on the targeting of the epileptogenic zone previously localized very precisely by stereoelectroencephalography (SEEG). SEEG is used as part of the pre-surgical assessment. It consists, thanks to the intracerebral implantation of electrodes in the brain of patients, to perform an intracerebral electrophysiological recording and thus to precisely explore the epileptogenic regions. In order to study the neuromodulatory and therapeutic effects of tDCS on epileptic brains, non-invasive techniques for measuring electrophysiological brain activity such as magnetoencephalography (MEG) and high-resolution electroencephalography (HR EEG) will be used. Finally, since epilepsy is considered to be a disorder of brain functional networks associated with disturbed brain connectivity, the effects of tDCS on cortical excitability by studying the variations in functional connectivity induced by stimulation will be studied.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 4, 2021

Completed
11 days until next milestone

Study Start

First participant enrolled

March 15, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 21, 2024

Completed
Last Updated

May 8, 2026

Status Verified

February 1, 2024

Enrollment Period

1.9 years

First QC Date

February 26, 2021

Last Update Submit

May 4, 2026

Conditions

Keywords

pharmaco-resistant epilepsytranscranial stimulationSEEG

Outcome Measures

Primary Outcomes (4)

  • Seizure frequency

    Percentage of change of seizures frequency

    Comparison between baseline and month 2

  • Seizure frequency

    Percentage of change of seizures frequency

    Comparison between baseline and month 4

  • Seizure frequency

    Percentage of change of seizures frequency

    Comparison between baseline and month 6

  • Seizure frequency

    Percentage of change of seizures frequency

    Comparison between baseline and month 8

Secondary Outcomes (4)

  • Depression

    Comparison between baseline and month 8

  • Anxiety disorders

    Comparison between baseline and month 8

  • Seizures evaluation

    Comparison between baseline and month 8

  • Brain functional connectivity

    Comparison between day 1 and day 5 of each session

Study Arms (1)

tDCS (transcranial direct current stimulation)

EXPERIMENTAL

Patient will be treated for 3 cycles. A cycle is composed of 5 bi-sessions (one per day) of 20 minutes each.

Device: transcranial direct current stimulation

Interventions

Patients will be treated using Starstim 8 device, a device allowing to perform transcranial direct current stimulation. The position of electrodes will be personalized based on the localization of the epileptogenic zone.

tDCS (transcranial direct current stimulation)

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • \- Age: Older than 12 years old
  • Patients with drug-resistant focal epilepsy with no surgical indication or with a previous surgical failure or refusing surgery.
  • A clinical or research MRI scan that is suitable for navigated brain stimulation (NBS) and definition of target area.
  • Number of seizures \>3/month during the baseline (before the first session of tDCS treatment), for at least 3 months
  • Have stable medications for the whole study duration and few weeks before
  • Total IQ\>65
  • Be able to understand, speak and write in French
  • Patient, parents or legally representative who have given written informed consent to allow the study data collection procedures,
  • Be a beneficiary of affiliated to a health insurance plan

You may not qualify if:

  • \- Generalized epilepsy
  • Presenting contraindication to MRI, a serious intercurrent pathology, a progressive brain tumor
  • Skin conditions (e.g., eczema, lesion)
  • Any cranial metal implants (excluding \<1 mm thick epicranial titanium skull plates and dental fillings) or medical devices (i.e. cardiac pacemaker, deep brain stimulator, medication infusion pump, cochlear implant).
  • Previous surgeries opening the skull leaving skull defects capable of allowing the insertion of a cylinder with a radius greater or equal to 5 mm.
  • Metal inside the head (outside the mouth) such as shrapnel, surgical clips
  • Any condition that makes the study subject, in the opinion of the investigator, unsuitable for the study.
  • Person protected by articles L1121-5, L1121-6 and L1121-8 of Public Health Code (pregnant or breastfeeding woman, deprived of liberty by judicial decision, situations of social fragility, adults unable or unable to express their consent).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service d'Epileptologie et de Rythmologie Cérébrale

Marseille, 13005, France

Location

Related Publications (1)

  • Bartolomei F, Daoud M, Delourme M, Tardoski S, Makhalova J, Bourguiba E, Medina Villalon S, Lagarde S, Wendling F, Ruffini G, Salvador R, Pizzo F, Giusiano B. Personalized multichannel transcranial direct current electrical stimulation (tDCS) in drug-resistant epilepsy: A SEEG based open-labeled study. Epilepsia Open. 2025 Aug;10(4):1034-1042. doi: 10.1002/epi4.70055. Epub 2025 May 10.

MeSH Terms

Conditions

Epilepsy

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Jean-Olivier Arnaud

    AP-HM

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2021

First Posted

March 4, 2021

Study Start

March 15, 2021

Primary Completion

February 20, 2023

Study Completion

February 21, 2024

Last Updated

May 8, 2026

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations